We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+10.39%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$716M
AUM Growth
+$28.2M
Cap. Flow
-$7.46M
Cap. Flow %
-1.04%
Top 10 Hldgs %
16.05%
Holding
426
New
40
Increased
110
Reduced
102
Closed
56

Top Buys

Rank Stock Value
1
PRIM icon
Primoris Services
PRIM
+$6.62M
2
XYL icon
Xylem
XYL
+$5.51M
3
GMED icon
Globus Medical
GMED
+$5.42M
4
NEWR
New Relic, Inc.
NEWR
+$4.87M
5
BOX icon
Box
BOX
+$4.76M

Sector Composition

Rank Sector Weight
1 Technology 28.28%
2 Industrials 23.37%
3 Healthcare 15.83%
4 Materials 7.53%
5 Consumer Discretionary 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WOLF icon
101
Wolfspeed
WOLF
$1.65B
$2.46M 0.34%
44,315
-15,316
-26% -$780K
DDD icon
102
3D Systems Corp
DDD
$603M
$2.46M 0.34%
247,368
-57,102
-19% -$522K
TBBK icon
103
The Bancorp
TBBK
$2.83B
$2.44M 0.34%
74,814
+8,814
+13% +$271K
SSYS icon
104
Stratasys
SSYS
$767M
$2.41M 0.34%
135,968
+19,986
+17% +$313K
NVRI icon
105
Enviri
NVRI
$583M
$2.4M 0.34%
+243,358
New +$2.01M
INSM icon
106
Insmed
INSM
$28.9B
$2.3M 0.32%
109,182
+16,022
+17% +$304K
INMD icon
107
InMode
INMD
$876M
$2.3M 0.32%
+61,545
New +$2.15M
BKSY icon
108
BlackSky Technology
BKSY
$1.3B
$2.28M 0.32%
128,449
+40,865
+47% +$488K
B
109
Barrick Mining
B
$67.9B
$2.28M 0.32%
134,634
-2,178
-2% -$39.7K
FIVE icon
110
Five Below
FIVE
$13.2B
$2.27M 0.32%
11,555
+1,666
+17% +$326K
MTDR icon
111
Matador Resources
MTDR
$6.5B
$2.23M 0.31%
42,630
+2,288
+6% +$111K
UFI icon
112
UNIFI
UFI
$127M
$2.22M 0.31%
+275,085
New +$2.16M
EVCM icon
113
EverCommerce
EVCM
$1.76B
$2.21M 0.31%
186,351
+27,130
+17% +$317K
AXP icon
114
American Express
AXP
$232B
$2.19M 0.31%
12,597
-1,726
-12% -$278K
PAY icon
115
Paymentus
PAY
$5.08B
$2.19M 0.31%
+207,682
New +$1.94M
F icon
116
Ford
F
$55.1B
$2.19M 0.31%
144,611
+54,715
+61% +$692K
CUTR
117
DELISTED
Cutera, Inc.
CUTR
$2.19M 0.31%
144,538
+122
+0.1% +$2.31K
GFF icon
118
Griffon
GFF
$4.75B
$2.13M 0.3%
52,838
+22,840
+76% +$749K
PAYO icon
119
Payoneer
PAYO
$2.41B
$2.11M 0.29%
+438,849
New +$2.19M
NARI
120
DELISTED
Inari Medical, Inc. Common Stock
NARI
$2.11M 0.29%
+36,265
New +$2.29M
AREC icon
121
American Resources Corp
AREC
$300M
$2.1M 0.29%
1,072,470
+126,514
+13% +$193K
PFE icon
122
Pfizer
PFE
$150B
$2.09M 0.29%
56,844
-40,254
-41% -$1.57M
LXFR icon
123
Luxfer Holdings
LXFR
$457M
$2.08M 0.29%
145,903
+17,344
+13% +$266K
PG icon
124
Procter & Gamble
PG
$335B
$2.06M 0.29%
13,563
STXS icon
125
Stereotaxis
STXS
$139M
$2.04M 0.29%
1,334,934
+471,010
+55% +$873K

Similar funds

Essex Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, Essex Investment Management held 426 positions worth $716M, up 4.1% from $688M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Essex Investment Management's Q2 2023 filing shows 40 new, 110 increased, 102 reduced and 56 closed positions. Its largest new stake was Primoris Services: 247,370 shares worth $7.54M. The largest sale was Castle Biosciences, an estimated $10.9M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Industrials and Healthcare.

  • Essex Investment Management's largest Q2 2023 buy was Primoris Services: 247,370 shares worth $7.54M.
  • Essex Investment Management added most to Xylem in Q2 2023, an estimated $5.51M increase.
  • Essex Investment Management's biggest Q2 2023 reduction was Energy Recovery, cutting an estimated $4.08M.
  • Essex Investment Management fully exited Castle Biosciences in Q2 2023, selling an estimated $10.9M.
  • Essex Investment Management's ten largest holdings make up 16% of its $716M portfolio in Q2 2023.
  • Essex Investment Management opened 40 new positions and closed 56 in Q2 2023.
  • Essex Investment Management's portfolio value rose 4.1% quarter-over-quarter to $716M.

Based on Essex Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.